The first infrastructure rail that turns clinical recommendations into automated revenue and evidence-aligned care without changing the clinical workflow.
The rail is ambient.
The workflow is unchanged.
The economics are transformed.
Outpatient healthcare has spent a decade digitizing records, automating billing, and layering AI onto documentation — but one part of the clinical workflow has remained untouched: the moment a provider recommends something.
Every day, clinicians recommend braces, equipment, skincare, supplements, and recovery tools. These recommendations shape patient behavior and drive billions in downstream spend.
Yet the infrastructure to capture, automate, and fulfill those recommendations simply doesn't exist.
Clinics influence the purchase. Patients trust the provider. But the revenue goes somewhere else. This is the gap. This is the category.
Revytal was born from eight years inside outpatient care — where margins are tight, reimbursement is shrinking, and clinics are desperate for revenue that isn't tied to insurance.
Providers see it every day: a brace recommended in the clinic becomes an Amazon purchase; a topical becomes a CVS run; equipment becomes a Google search. The clinic drives the intent. The patient trusts the provider. But the economics leak out of the system.
This isn't a workflow problem. It's an infrastructure problem. And no one has built the rail that connects clinical intent to patient action.
Clinical Commerce Infrastructure is the rail that connects provider intent to patient action — automatically, compliantly, and without adding steps to the clinical workflow.
Not a storefront
Not a marketplace
Not an affiliate layer
It is infrastructure — a background system that listens to the clinical moment and turns it into revenue, fulfillment, and closed‑loop care.
Providers recommend → Revytal captures the intent
Patients receive a clean, curated path to purchase
Suppliers fulfill directly to the patient
Clinics earn revenue without inventory, logistics, or operational drag
Revytal begins by validating the analog version — proving the workflow, mapping the supplier stack, and demonstrating that the rail can exist without adding friction to clinical care.
But the infrastructure carries more than transactions.
As recommendations flow through the rail, patterns emerge. Which products correlate with better adherence. Which SKUs clinicians reach for across similar diagnoses. Where the evidence base and clinical habit diverge. Revytal surfaces these signals back to providers — not as alerts or interruptions, but as ambient, evidence-aligned context that sharpens clinical reasoning without adding a single step.
The revenue loop realigns incentives — clinics finally participate in the value they create.
The evidence loop raises the floor of care — clinicians make better-supported decisions over time.
Revytal sits at the intersection of both. Infrastructure that pays clinics and makes them better. That is the model worth building.
Revytal sits quietly in the background, turning clinical intent into automated commerce.
The full loop — from clinical intent to closed-loop care — runs automatically. The clinician does nothing more than recommend.
Reimbursement is unpredictable, delayed, and often declining. Clinics survive by optimizing schedules, negotiating rates, and squeezing efficiency out of workflows already stretched thin.
But one economic truth is universal: patients buy what clinicians recommend — clinics simply don't participate in the value they create.
Billions in downstream spend flow through outpatient care every year, and clinics capture none of it. Revytal changes the economics without changing the workflow.
The revenue loop is the entry point. But it is not the whole story.
As recommendations flow through the rail, patterns emerge across the clinical network — which products correlate with better adherence, where clinical habit and the evidence base diverge. That signal feeds back to providers as ambient, evidence-aligned context. No interruptions. No added steps.
The revenue loop realigns incentives. The evidence loop raises the floor of care. The revenue loop is the entry point. The evidence loop is what makes it defensible long-term.
This is not a behavior change problem. It's a missing infrastructure layer.
Clinicians want revenue not tied to insurance. The incentive alignment is immediate and obvious.
Patients already act on clinical recommendations. The behavior exists. The infrastructure doesn't.
Suppliers want direct‑to‑patient distribution rooted in clinical trust, not consumer advertising.
The analog workflow already works — Revytal simply captures it and automates what happens next.
As ambient AI becomes the operating system of outpatient care, two layers are missing simultaneously — the infrastructure that routes clinical recommendations into automated revenue, and the signal layer that turns those recommendations into evidence over time.
AI scribes capture the clinical encounter. Recommendations are becoming structured signals — and structured signals can feed both commerce and evidence loops.
The workflow overhead is collapsing. The clinical moment is surfacing — and it needs a commerce layer to complete it and an evidence layer to learn from it.
Clinics need revenue that isn't tied to insurance. Revytal delivers it — and pairs it with evidence-aligned insights that make the recommendation itself more defensible.
No competitor owns Clinical Commerce Infrastructure. No one is building the evidence layer on top of it. The first credible player names both and sets the terms.
The rail is inevitable. The evidence layer is what makes it matter. The only question is who builds both first.
The future of outpatient care is ambient. Documentation, scheduling, billing, and communication are all moving toward invisible automation — systems that listen, understand, and act.
But one part of the workflow has remained untouched: the moment a clinician recommends something. That moment generates two things simultaneously — a transaction and a signal. Revytal captures both.
A seamless way to participate in downstream product revenue without inventory, logistics, or workflow change.
A direct‑to‑patient distribution channel rooted in clinical trust, not consumer advertising spend.
A new category of healthcare infrastructure at the idea stage — with a clear problem, a clear wedge, and a clear path to inevitability.
Revytal is the commerce layer beneath the next decade of clinical automation.
Whether you're a clinic operator, supplier, or investor — if you see the gap, we want to hear from you.
will@mendtherapyla.com